Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.4K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.4K
Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

537
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
537
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

3.6K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.6K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

326
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
326
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

9.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.1K
Aryldiazonium Salts to Azo Dyes: Diazo Coupling01:11

Aryldiazonium Salts to Azo Dyes: Diazo Coupling

3.3K
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the para...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integration of functional immunomonitoring assays with PET/CT scans in TB patients identifies on-treatment biomarkers.

bioRxiv : the preprint server for biology·2026
Same author

4‑Aminoalkylquinolines as Potent Antitubercular Agents Targeting the Cytochrome bc<sub>1</sub> Complex.

ACS medicinal chemistry letters·2026
Same author

Psychedelics and Entactogens.

Journal of medicinal chemistry·2026
Same author

The Human Chk1 Inhibitor CHIR-124 Shows Multistage Activity against the Human Malaria Parasite <i>Plasmodium falciparum</i> via Polypharmacological Inhibition of <i>Pf</i>Ark1 and Hemozoin Formation.

ACS chemical biology·2026
Same author

Synthesis of 4-Aminoindole-Containing Cephalosporin Prodrugs and Their Biological Activity against <i>Mycobacterium tuberculosis</i>.

ACS infectious diseases·2026
Same author

Development of Isoniazid-Pyrazole Hybrids as Potential Antitubercular Agents.

International journal of molecular sciences·2026

Related Experiment Video

Updated: Nov 23, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.8K

Antitubercular 2-Pyrazolylpyrimidinones: Structure-Activity Relationship and Mode-of-Action Studies.

Candice Soares de Melo1, Vinayak Singh2,3, Alissa Myrick2

  • 1Drug Discovery and Development Centre (H3D), Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa.

Journal of Medicinal Chemistry
|January 4, 2021
PubMed
Summary
This summary is machine-generated.

Researchers discovered novel 2-pyrazolylpyrimidinones effective against Mycobacterium tuberculosis (Mtb). These compounds exhibit bactericidal activity and suggest a new mechanism of action involving iron homeostasis disruption.

More Related Videos

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

1.8K
Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
05:07

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines

Published on: June 23, 2019

6.9K

Related Experiment Videos

Last Updated: Nov 23, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.8K
Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

1.8K
Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
05:07

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines

Published on: June 23, 2019

6.9K

Area of Science:

  • Medicinal Chemistry
  • Microbiology
  • Drug Discovery

Background:

  • Tuberculosis (TB) remains a significant global health threat, necessitating the development of new anti-TB agents.
  • Existing treatments face challenges due to drug resistance and long treatment durations.
  • Novel therapeutic targets and drug candidates are crucial for combating Mycobacterium tuberculosis (Mtb).

Purpose of the Study:

  • To identify novel anti-tubercular compounds from the Medicines for Malaria Venture (MMV) compound library.
  • To investigate the mechanism of action of newly identified Mtb inhibitors.
  • To establish structure-activity relationships (SAR) for lead compounds.

Main Methods:

  • Phenotypic screening of the MMV compound library against Mtb.
  • Biology triage using Mtb tool strains to elucidate mechanism of action.
  • Resistance studies with MmpL3 mutant strains and MmpL3 hypomorphs.
  • RNA transcriptional profiling and checkerboard assays to assess iron homeostasis.
  • In vitro assays for physicochemical properties, metabolic stability, and cytotoxicity.

Main Results:

  • Identification of a cluster of pan-active 2-pyrazolylpyrimidinones against Mtb.
  • Compounds demonstrated bactericidal activity against replicating Mtb and clinical isolates.
  • Evidence suggested MmpL3 mutations as a potential resistance mechanism, but not necessarily the direct target.
  • Compounds were found to perturb iron (Fe) homeostasis in Mtb.
  • SAR studies yielded potent compounds with favorable in vitro properties and moderate cytotoxicity.

Conclusions:

  • 2-pyrazolylpyrimidinones represent a promising class of novel anti-TB drug candidates.
  • The compounds likely act via a novel mechanism involving disruption of Fe homeostasis.
  • Further optimization and in vivo studies are warranted to develop these compounds into viable TB therapeutics.